Harmony Biosciences Holdings, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US4131971040
USD
28.57
0.24 (0.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
868.45
714.73
582.02
437.86
305.44
159.74
6.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
868.45
714.73
582.02
437.86
305.44
159.74
6.00
Raw Material Cost
198.34
180.66
145.08
106.45
73.94
27.74
4.79
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
14.65
17.50
23.76
18.80
24.19
28.22
6.07
Selling and Distribution Expenses
272.05
197.42
168.85
140.34
113.60
95.57
77.52
Other Expenses
17.49
12.83
5.23
5.21
0.62
-0.88
6.35
Total Expenditure (Excl Depreciation)
659.98
523.91
389.99
317.67
217.91
142.76
151.90
Operating Profit (PBDIT) excl Other Income
208.5
190.79999999999998
192
120.19999999999999
87.5
17
-145.9
Other Income
21.24
18.47
14.89
3.29
0.24
-3.07
0.00
Operating Profit (PBDIT)
253.56
233.41
231.28
146.87
106.61
24.15
-142.69
Interest
14.65
17.50
23.76
18.80
24.19
28.22
6.07
Exceptional Items
0.00
0.00
-9.77
0.00
-26.15
-22.64
0.00
Gross Profit (PBDT)
670.11
534.07
436.94
331.41
231.50
132.00
1.21
Depreciation
23.85
24.11
24.36
23.39
18.84
10.24
3.21
Profit Before Tax
215.06
191.80
173.40
104.69
37.43
-36.94
-151.98
Tax
56.38
46.31
44.54
-76.78
2.83
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
158.69
145.49
128.85
181.47
34.60
-36.94
-151.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
158.69
145.49
128.85
181.47
34.60
-36.94
-151.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
158.69
145.49
128.85
181.47
34.60
-36.94
-151.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
870.22
659.15
466.99
402.84
186.51
97.18
-422.86
Earnings per share (EPS)
2.71
2.51
2.13
2.97
0.58
-1.12
-3.29
Diluted Earnings per share
2.71
2.51
2.13
2.97
0.58
-1.12
-3.29
Operating Profit Margin (Excl OI)
24.0%
26.7%
32.99%
27.45%
28.66%
10.63%
-2433.76%
Gross Profit Margin
27.51%
30.21%
33.98%
29.25%
18.42%
-16.72%
-2481.52%
PAT Margin
18.27%
20.36%
22.14%
41.44%
11.33%
-23.13%
-2535.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 21.52% vs 22.80% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 9.07% vs 12.88% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 8.10% vs -0.69% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -16.57% vs -26.47% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Harmony Biosciences Holdings, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
868.45
7.50
860.95
11,479.33%
Other Operating Income
0.00
0.00
0.00
Total Operating income
868.45
7.50
860.95
11,479.33%
Raw Material Cost
198.34
2.54
195.80
7,708.66%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
143.41
-143.41
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
14.65
0.00
14.65
Selling and Distribution Expenses
272.05
79.63
192.42
241.64%
Other Expenses
17.49
15.50
1.99
12.84%
Total Expenditure (Excl Depreciation)
659.98
380.57
279.41
73.42%
Operating Profit (PBDIT) excl Other Income
208.47
-373.07
581.54
155.88%
Other Income
21.24
28.18
-6.94
-24.63%
Operating Profit (PBDIT)
253.56
-342.35
595.91
174.06%
Interest
14.65
0.00
14.65
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
670.11
4.96
665.15
13,410.28%
Depreciation
23.85
2.54
21.31
838.98%
Profit Before Tax
215.06
-344.89
559.95
162.36%
Tax
56.38
1.02
55.36
5,427.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
158.69
-345.91
504.60
145.88%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
158.69
-345.91
504.60
145.88%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
158.69
-345.91
504.60
145.88%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
870.22
581.76
288.46
49.58%
Earnings per share (EPS)
2.71
-4.36
7.07
162.16%
Diluted Earnings per share
2.71
-4.36
7.07
162.16%
Operating Profit Margin (Excl OI)
24.00%
-4,974.27%
0.00
4,998.27%
Gross Profit Margin
27.51%
-4,564.68%
0.00
4,592.19%
PAT Margin
18.27%
-4,612.13%
0.00
4,630.40%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 86.85 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 21.52% vs 22.80% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 15.87 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 9.07% vs 12.88% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.23 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 8.10% vs -0.69% in Dec 2024

Annual - Interest
Interest 1.46 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -16.57% vs -26.47% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 24.00%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024